Ipamorelin
Growth HormoneOverview
A selective ghrelin/GH-secretagogue studied for stimulating GH release with minimal effect on cortisol or prolactin; researched for recovery, sleep and body composition.
Mechanism of Action
Ipamorelin is a selective ghrelin receptor (growth hormone secretagogue receptor, GHSR) agonist that has been studied for its ability to stimulate growth hormone (GH) release from the pituitary. Compared with some other GH secretagogues, it is often described as relatively selective, with minimal observed stimulation of cortisol or prolactin in preclinical and human research contexts.
Reported Research Observations
In research settings, ipamorelin has been observed to increase circulating GH and to support downstream IGF-1 signaling, which is why it has been explored in studies related to recovery, sleep, and body composition. Researchers have also examined it for potential effects on tissue repair and anabolic markers, although findings vary by model, protocol, and population.
Quick Facts
- Commonly Available Vial Sizes
- 2 mg, 5 mg, 10 mg, 20 mg
- Typical Research Dose
- 200 – 300 mcg
- Suggested BAC Water
- 2 mL
- Category
- Growth Hormone
Safety & Handling
Ipamorelin is a research-use-only compound and should be handled according to laboratory safety procedures and the supplier’s storage guidance. In research contexts, it is commonly reconstituted with bacteriostatic water and stored refrigerated after preparation, with attention to sterility, contamination control, and stability limits described by the manufacturer or study protocol. It is not approved as a general consumer product, and information here is for laboratory reference only.
Notes
Available in 2mg, 5mg, 10mg vials | Dosing: 1-3 times daily, 8-12 weeks on, 2-4 weeks off. Route: Subcutaneous (SC)
Commonly Researched Together
Further Reading
For laboratory and research use only. Not for human consumption or clinical use. Information is provided for reference and does not constitute medical advice.